Quantum-Si (HighCape Capital Acq.) ^{Priced, Nasdaq: QSI}

We are a newly organized blank check company. Our strategy will be to identify, acquire and, after our initial business combination, build, a life sciences or life sciences related business. We intend to focus our investment effort broadly across the entire life sciences industry, which encompasses therapeutics, devices, diagnostics, medical information technology, agrisciences and animal health. We were formed by HighCape, a life sciences investment firm with a focus on active investing in commercial stage companies. HighCape typically invests in companies that have FDA cleared products and are at the point of product launch or have already generated revenue for multiple years. HighCape’s expertise in working with companies at this stage of development is what makes it unique. We believe that the experience of HighCape’s partners and advisors and our management team and board of directors will allow us to source, identify and execute an attractive transaction for our stockholders. Our management team is led by Kevin Rakin, our chief executive officer, who has more than 30 years of experience in leading, investing and exiting life sciences companies across a wide array of products and services.